Liraglutide as an Additional Treatment to Insulin in Patients with

liraglutide  liraglutide NAME OF THE MEDICINE Victoza (liraglutide ) 6 mgmL solution for injection in a pre-filled pen Liraglutide has the Liraglutide is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-

Liraglutide is a human glucagon-like peptide-1 receptor agonist and an established antidiabetic medication It leads to weight loss by slowing gastric Conclusions Liraglutide helps to induce and sustain weight loss in patients with obesity Its efficacy is comparable to other available agents

Conclusions In this meta-analysis, 18 RCTs were included to explore the effect of liraglutide on blood pressure The results showed that Liraglutide is a long-acting glucagon-like peptide-1 receptor agonist Free Delivery on orders over $ 500 Order now